Charged Particle and Conventional Radiotherapy: Current Implications as Partner for Immunotherapy
Radiotherapy (RT) has been shown to interfere with inflammatory signals and to enhance tumor immunogenicity via, e.g., immunogenic cell death, thereby potentially augmenting the therapeutic efficacy of immunotherapy. Conventional RT consists predominantly of high energy photon beams. Hypofractionate...
Main Authors: | Damiënne Marcus, Relinde I. Y. Lieverse, Carmen Klein, Amir Abdollahi, Philippe Lambin, Ludwig J. Dubois, Ala Yaromina |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-03-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/6/1468 |
Similar Items
-
Radiotherapy in Combination With Cytokine Treatment
by: Ondrej Palata, et al.
Published: (2019-05-01) -
MR-Guided Radiotherapy: The Perfect Partner for Immunotherapy?
by: Juliane Hörner-Rieber, et al.
Published: (2021-02-01) -
Enhancing the efficacy of immunotherapy using radiotherapy
by: Synat Keam, et al.
Published: (2020-01-01) -
Immunotherapy as sensitizer for local radiotherapy
by: Ben G.L. Vanneste, et al.
Published: (2020-01-01) -
The Confluence of Radiotherapy & Immunotherapy
by: Ralph Robert Weichselbaum, et al.
Published: (2012-10-01)